These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

870 related items for PubMed ID: 21830922

  • 1. Bayesian approach to noninferiority trials for proportions.
    Gamalo MA, Wu R, Tiwari RC.
    J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
    [Abstract] [Full Text] [Related]

  • 2. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
    Osman M, Ghosh SK.
    J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
    [Abstract] [Full Text] [Related]

  • 3. Bayesian approach to non-inferiority trials for normal means.
    Gamalo MA, Wu R, Tiwari RC.
    Stat Methods Med Res; 2016 Feb; 25(1):221-40. PubMed ID: 22619277
    [Abstract] [Full Text] [Related]

  • 4. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM, Wang SJ, O'Neill R.
    J Biopharm Stat; 2007 Feb; 17(2):201-13. PubMed ID: 17365218
    [Abstract] [Full Text] [Related]

  • 5. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ, Lipsky AM, Berry DA.
    Clin Trials; 2007 Feb; 4(1):5-14. PubMed ID: 17327241
    [Abstract] [Full Text] [Related]

  • 6. Bayesian approach for assessing noninferiority in a three-arm trial with binary endpoint.
    Ghosh S, Tiwari RC, Ghosh S.
    Pharm Stat; 2018 Jul; 17(4):342-357. PubMed ID: 29473291
    [Abstract] [Full Text] [Related]

  • 7. A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.
    Kikuchi T, Gittins J.
    Stat Methods Med Res; 2011 Aug; 20(4):389-400. PubMed ID: 20223784
    [Abstract] [Full Text] [Related]

  • 8. Randomization as a basis for inference in noninferiority trials.
    Wiens BL.
    Pharm Stat; 2006 Aug; 5(4):265-71. PubMed ID: 17128425
    [Abstract] [Full Text] [Related]

  • 9. Assessing noninferiority in a three-arm trial using the Bayesian approach.
    Ghosh P, Nathoo F, Gönen M, Tiwari RC.
    Stat Med; 2011 Jul 10; 30(15):1795-808. PubMed ID: 21520456
    [Abstract] [Full Text] [Related]

  • 10. Practical Bayesian design and analysis for drug and device clinical trials.
    Hobbs BP, Carlin BP.
    J Biopharm Stat; 2008 Jul 10; 18(1):54-80. PubMed ID: 18161542
    [Abstract] [Full Text] [Related]

  • 11. Three-arm noninferiority trials with a prespecified margin for inference of the difference in the proportions of binary endpoints.
    Hida E, Tango T.
    J Biopharm Stat; 2013 Jul 10; 23(4):774-89. PubMed ID: 23799810
    [Abstract] [Full Text] [Related]

  • 12. Bayesian noninferiority test for 2 binomial probabilities as the extension of Fisher exact test.
    Doi M, Takahashi F, Kawasaki Y.
    Stat Med; 2017 Dec 30; 36(30):4789-4803. PubMed ID: 28960376
    [Abstract] [Full Text] [Related]

  • 13. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A.
    J Clin Epidemiol; 2009 Jan 30; 62(1):13-21.e5. PubMed ID: 18947971
    [Abstract] [Full Text] [Related]

  • 14. Making sense of noninferiority: a clinical and statistical perspective on its application to cardiovascular clinical trials.
    Kaul S, Diamond GA.
    Prog Cardiovasc Dis; 2007 Jan 30; 49(4):284-99. PubMed ID: 17185116
    [Abstract] [Full Text] [Related]

  • 15. Bayesian approaches in medical device clinical trials: a discussion with examples in the regulatory setting.
    Bonangelino P, Irony T, Liang S, Li X, Mukhi V, Ruan S, Xu Y, Yang X, Wang C.
    J Biopharm Stat; 2011 Sep 30; 21(5):938-53. PubMed ID: 21830924
    [Abstract] [Full Text] [Related]

  • 16. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y, Zhang J, Levenson M.
    J Biopharm Stat; 2007 Sep 30; 17(2):279-88. PubMed ID: 17365224
    [Abstract] [Full Text] [Related]

  • 17. Comparing methods for calculating confidence intervals for vaccine efficacy.
    Ewell M.
    Stat Med; 2007 Sep 30; 15(21-22):2379-92. PubMed ID: 8931208
    [Abstract] [Full Text] [Related]

  • 18. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y, Chen WJ.
    J Biopharm Stat; 2007 Sep 30; 17(2):289-308. PubMed ID: 17365225
    [Abstract] [Full Text] [Related]

  • 19. Likelihood ratio and a Bayesian approach were superior to standard noninferiority analysis when the noninferiority margin varied with the control event rate.
    Kim MY, Xue X.
    J Clin Epidemiol; 2004 Dec 30; 57(12):1253-61. PubMed ID: 15617951
    [Abstract] [Full Text] [Related]

  • 20. Bayesian hypothesis testing in two-arm trials with dichotomous outcomes.
    Zaslavsky BG.
    Biometrics; 2013 Mar 30; 69(1):157-63. PubMed ID: 23002906
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.